Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China (Q82371964)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 October 2010
edit
Language Label Description Also known as
English
Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China
scientific article published on 12 October 2010

    Statements

    Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit